Three-Drug Combinations for the Treatment of Carbapenem-Resistant A. baumannii
收藏NIAID Data Ecosystem2026-03-13 收录
官方服务：
资源简介：
Three-Drug Combinations for the Treatment of Carbapenem-Resistant A. baumannii
应用场景：
创建时间：
2022-06-25
相关数据集
Rezzoagli_etal_2020_rawdata.xlsx
This item contains all the raw data of the paper by Rezzoagli et al. Combining antibiotics with antivirulence compounds can have synergistic effects and reverse selection for antibiotic resistance in
NIAID Data Ecosystem30
Data_Sheet_2_Improved in vitro Efficacy of Baloxavir Marboxil Against Influenza A Virus Infection by Combination Treatment With the MEK Inhibitor ATR-002.PDF
Currently, all available antiviral drugs against influenza virus (IV) that target the virus proteins directly, like Baloxavir acid (BXA), lead to viral resistance. Therefore, cellular mechanisms and f
NIAID Data Ecosystem20
Combination testing of thiazole compounds 1–3 with mupirocin against clinically-prevalent strains of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA).
1 ƩFIC, fractional inhibitory concentration index. Results for the FIC index (ƩFIC) are as follows: ≤ 0.50, synergistic; >0.50 to ≤4.00, indifference; >4.00, antagonistic. ƩFIC range provided is from
Figshare2015-12-03 更新10
Two-Drug Antimicrobial Chemotherapy: A Mathematical Model and Experiments with Mycobacterium marinum
Multi-drug therapy is the standard-of-care treatment for tuberculosis. Despite this, virtually all studies of the pharmacodynamics (PD) of mycobacterial drugs employed for the design of treatment prot
Figshare2016-01-18 更新20
Table_3_Combination of a Latency-Reversing Agent With a Smac Mimetic Minimizes Secondary HIV-1 Infection in vitro.pdf
Latency-reversing agents (LRAs) are considered a potential tool to cure human immunodeficiency virus type 1 (HIV-1) infection, but when they are taken alone, virus production by reactivated cells and
NIAID Data Ecosystem20
